<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03484546</url>
  </required_header>
  <id_info>
    <org_study_id>AcibademGynecology</org_study_id>
    <nct_id>NCT03484546</nct_id>
  </id_info>
  <brief_title>Optimum Menstrual Cycle Time for Endometrioma Excision</brief_title>
  <official_title>Optimum Menstrual Cycle Time for Endometrioma Excision</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acibadem University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acibadem University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the optimum day of menstrual period for the excision of endometriomas to
      minimize the damage of surgery to normal ovarian tissue. Patients will be grouped as
      follicular, ovulatory and luteal according to menstrual days. Ovarian damage will be
      evaluated with both pathologic examination and anti-mullerian hormone levels before and after
      the surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endometriosis is a common gynecologic disease seen in about 10% of women in reproductive age.
      The most common site of endometriosis is overt. Cystic formation of ovarian endometriosis is
      called endometrioma (chocolate cyst). Definitive treatment of endometriomas is excision by
      laparoscopy. The disadvantage of this surgery is the removal of some of the normal ovarian
      follicles within cystectomy material. This procedure can damage the ovarian reserves with the
      treatment of endometriomas, which are already the cause of infertility, and lead to the
      conditions such as infertility or early menopause. It has been understood that the ovarian
      reserves of the patients who underwent endometrioma cystectomy with the decrease of the
      Anti-Mullerian Hormone values, which is an over reserve parameter.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2018</start_date>
  <completion_date type="Anticipated">January 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of ovarian follicle damage via histological examination</measure>
    <time_frame>5 days after the surgery</time_frame>
    <description>Histologic evaluation of the cystectomy excision material for health ovarian follicles</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of anti-mullerian hormone level 6 months after surgery</measure>
    <time_frame>6 months</time_frame>
    <description>Comparison of pre-operative and 6 months after surgery of anti-mullerian hormone levels</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Endometriosis</condition>
  <condition>Endometrioma</condition>
  <arm_group>
    <arm_group_label>folicular</arm_group_label>
    <description>Women who will undergo endometrioma cystectomy in her follicular phase of menstrual period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ovulatory</arm_group_label>
    <description>Women who will undergo endometrioma cystectomy in her ovulatory phase (12-14th day of mestrual period cycle for women regular period) of menstrual cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>luteal</arm_group_label>
    <description>Women who will undergo endometrioma cystectomy in her luteal phase of menstrual period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic endometrioma cyst excision</intervention_name>
    <description>laparoscopic resection of ovarian endometrioma</description>
    <arm_group_label>folicular</arm_group_label>
    <arm_group_label>ovulatory</arm_group_label>
    <arm_group_label>luteal</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women who admitted to out-patient clinic between the ages of 18-40 years,had 4-10cm ovarian
        unilateral endometrioma and had an indication of laparoscopic ovarian endometrioma
        excision.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  4 to 10 cm unilateral ovarian endometrioma

          -  having clinically indication of laparoscopic ovarian endometrioma excision

        Exclusion Criteria:

          -  prior gynecologic surgery

          -  prior abdominal surgery

          -  additional operation in the same session

          -  having the diagnosis of premature ovarian failure or ovarian insufficiency

          -  having any diagnosis of malignancy

          -  having diagnosis of a non-gynecologic chronicle disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ozguc Takmaz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Acibadem MAA University Maslak Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ozguc Takmaz</last_name>
    <phone>00905554006591</phone>
    <email>ozguctakmaz@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mete Gungor</last_name>
    <phone>002123044970</phone>
    <email>mete.gungor@acibadem.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Acibadem Fulya Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34457</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ercan Bastu, MD,AssocProf</last_name>
      <phone>+905324134195</phone>
      <email>ercan.bastu@acibadem.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Acibadem MAA University Atakent Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34457</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emine Karabuk, MD</last_name>
      <phone>+905336487171</phone>
      <email>emine.karauk@acibadem.com</email>
    </contact>
    <contact_backup>
      <last_name>Murat Naki, MD,Prof</last_name>
      <phone>+905327706666</phone>
      <email>murat.naki@acibadem.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Acibadem MAA University Maslak Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34457</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ozguc Takmaz, MD,AssistProf</last_name>
      <phone>+905554006591</phone>
      <email>ozguctakmaz@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Mete Gungor, MD,Prof</last_name>
      <phone>+902123044970</phone>
      <email>mete.gungor@acibadem.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2018</study_first_submitted>
  <study_first_submitted_qc>March 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Acibadem University</investigator_affiliation>
    <investigator_full_name>Ozguc Takmaz</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>ovarian reserve</keyword>
  <keyword>endometriosis</keyword>
  <keyword>endometrioma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data sharing will be decided during the study process.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

